| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963901 | Vaccine | 2015 | 6 Pages |
Abstract
Our study detected the expected increased FS risk post MMR1 vaccine at 12 months, but monovalent varicella vaccine at age 18 months was not associated with increased risk of FS. This provides baseline data to assess the risk of FS post MMRV, introduced in Australia as the second dose of measles-containing vaccine at 18 months of age in July 2013.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kristine K. Macartney, Heather F. Gidding, Lieu Trinh, Han Wang, Jocelynne McRae, Nigel Crawford, Michael Gold, Anne Kynaston, Christopher Blyth, Zurynski Yvonne, Elizabeth Elliott, Robert Booy, Jim Buttery, Helen Marshall, Michael Nissen,